drugset / Trial / NCT07696091

Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

NCT07696091

Phase 1 Not yet recruiting 40 enrolled Reistone Biopharma Company Limited
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is a single-center, single-sequence, self-controlled, open design, aiming to investigate the effects of rifampicin and clarithromycin on the pharmacokinetics of RSS0343 in humans.

Timeline

Start
2026-07
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule
Subject RSS0343 Unknown
Subject Rifampin Small molecule